Physician profile
Gary Small
NPI 1295842946
$170,216.29
in general payments reported to CMS, 2019-2025
12 companies · $14.33 in 2025
The $14.33 reported for 2025 was less than what a typical Psychiatry provider received nationally (typical 2025 total: $176).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $26K · 2020: $46K · 2021: $28K · 2022: $44K · 2023: $10K · 2024: $16K · 2025: $14.33.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $12K · Travel and Lodging: $7,069 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $6,300 · Food and Beverage: $625.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $11,762.50 |
| Travel and Lodging | $7,068.61 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $6,300.00 |
| Food and Beverage | $625.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acadia Pharmaceuticals INC | $90,759.27 | 2019-2024 | Nuplazid |
| Eisai INC. | $17,848.31 | 2023-2024 | |
| Otsuka America Pharmaceutical, INC. | $16,548.17 | 2019-2022 | |
| Genentech USA, INC. | $12,909.99 | 2019-2022 | |
| Genentech, INC. | $6,792.50 | 2019-2022 | |
| Avanir Pharmaceuticals, INC. | $5,775.00 | 2021 | |
| Abbvie INC. | $5,470.72 | 2023-2024 | |
| F. Hoffmann-La Roche Ag | $5,280.00 | 2020 | |
| Biogen, INC. | $4,520.00 | 2020-2021 | |
| Corium, LLC | $4,275.00 | 2022 | |
| Lundbeck LLC | $23.00 | 2024 | Rexulti |
| E.R. Squibb & Sons, L.L.C. | $14.33 | 2025 | Cobenfy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gary Small listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.